“…In addition to the normal catalytic function of SOD1, there is evidence for a gain-of-function toxicity of SOD1 upon mutation. , Proteinaceous inclusions rich in mutant SOD1 are in tissues of ALS-SOD1 transgenic mice and ALS patients and in cell-culture models. , The fibrils or insoluble inclusions in ALS, however, are unlikely to be toxic because they arise in a relatively late stage of the disease . The ALS-inducing SOD1 mutants manifest a common shift of the folding equilibrium toward denatured and partially unfolded apo monomers, either disrupting the dimer interface, perturbing the monomer structure, or compromising the formation of mature (e.g., holo, disulfide-bonded) dimers. − Extensive studies show that the immature forms of SOD1, obtainable through intramolecular disulfide reduction, metal-ion removal, , heating, , and chemical induction, , readily form aggregates under physiological conditions, possibly owing to a decrease in the native SOD1 stability and/or an increase in the unfolding rates.…”